Investor Relations
We are excited to announce that Friulchem will be attending CPHI Milan, a leading event that brings together thousands of professionals from the pharmaceutical and chemical industries. This is a unique opportunity to exchange ideas, explore new innovations, and create valuable partnerships. Meet our team of experts to discover how Friulchem can support your business …
Friulchem S.p.A. , is delighted to announce that the Ministry of Agriculture of the People’s Republic of China has granted registration of two products of the Suppleo line, complementary feeds developed by Friulchem with its proprietary FC-Cubes® technology in the Vivaro factory. The Company can also confirm that it will be at Pet Fair Asia …
The partnership includes the supply of complementary feeds from the Suppleo line for the wellbeing of joints and the maintenance of mobility, and for the optimal modulation of the immune system in pets. Read more here CS_Friulchem _ Accordo Giappone def clean_EN
On Il Corriere Imprese – Nord Est, Alessandro Rinaldini dedicates an interesting article to Friulchem S.p.A. an insight into the Company, the latest news, and technologies such as the patented Fc-Cubes technology, which allows producing highly palatable chewable tablets to facilitate the administration of veterinary medicines. RS 24.04.2023 – Corriere Imprese EN
Friulchem has signed a collaboration agreement with a company in the veterinary sector for the exclusive supply of complementary feed in Australia and New Zealand with a formulation developed by Friulchem itself and based on the proprietary FC-Cubes technology. CS_Friulchem _ Accordo con azienda neozelandese_EN
FC FRANCE SAS is a CDMO specialized in the development, manufacture, and packaging of veterinary products in the non-sterile oral form: Soluble oral powder (POS) Medicated Premix (PM) Liquid (solution/suspension) Dough Intraruminal device (BOLUS) Secondary packaging Located 50 km from Paris in the Val d’Oise in Magny en Vexin, from July 2021, the site became …
Visit us in Frankfurt from November 01st-03rd at the CPhI Worldwide 2022 – booth 121D120.
Friulchem S.p.A. is pleased to announce that it has obtained authorization of a new patent application in France for chewable tablets, soon to be extended to other EU and non-EU countries.
FRIULCHEM FIRMA UN ACCORDO PRELIMINARE VINCOLANTE PER L’ACQUISTO DI UN RAMO DI AZIENDA PRODUTTIVO IN FRANCIA